Clinical Trials Logo

Clinical Trial Summary

De-identified whole blood and serum samples are collected for the purpose of evaluating the performance (sensitivity/specificity) of the HelioLiver Test for the detection of hepatocellular carcinoma (HCC).

Clinical Trial Description

The purpose of this study is to define the performance characteristics (sensitivity and specificity) of the Helio Liver Test within a study population of subjects that have been diagnosed with liver cancer at various stages (I to IV) and for control subjects who have been confirmed to not have liver cancer by at least one imaging technique, such as ultrasound, MRI or CT. Control subjects will include patients who are at high-risk for liver cancer and have been recommended to undergo liver cancer surveillance, as well as patients who have non-HCC cancers to determine analytical specificity. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05059665
Study type Observational
Source Laboratory for Advanced Medicine, Indiana
Status Completed
Start date April 20, 2020
Completion date July 1, 2021